血液検査を用いたアルツハイマー病スペクトラムの機械学習モデル
Nicola Walter Falasca1, Antonio Ferretti1,2,3, Alberto Granzotto1,4
1Department of Neuroscience, Imaging, and Clinical Sciences G. d'Annunzio University of Chieti-Pescara Chieti Italy.
Alzheimer's & dementia (Amsterdam, Netherlands)
|December 12, 2025
まとめ
血液検査を解析する機械学習モデルは、認知機能低下の初期兆候を検出できる。アミノ酸、リポタンパク質、脂肪酸が主要な予測因子であり、アルツハイマー病および軽度認知障害の診断に新たなアプローチを提供する。
さらに関連する動画
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
2.7K
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.9K
関連する概念動画
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752